| |
Article Title |
Author(s) |
Pages |
|
|
|
New Data, New Paradigms for Treating Patients With Prostate Cancer: Introduction
On December 12-13, 2009, a summit meeting of the national authorities on prostate cancer detection and treatment was convened in New York City to focus on the current attitudes and practice patterns o...
|
Judd W. Moul,
Robert Dreicer
|
S475
|
|
|
|
Focusing on Testosterone
Since Huggins and Hodges first established testosterone as the principal androgenic hormone responsible for the growth of prostate cancer in 1941, lowering the circulating testosterone to surgical cas...
|
Judd W. Moul,
Robert Dreicer
|
S476-S477
|
|
|
|
Indications and Practice With Androgen Deprivation Therapy
The Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE) is an ongoing longitudinal observational study of current trends in prostate cancer staging and treatment across a spectrum ...
|
Judd W. Moul,
Adam S. Kibel,
Mack Roach,
Robert Dreicer
|
S478-S481
|
|
|
|
Targeting the Androgen Receptor—Theory and Practice
Intensive investigation during the past 2 decades has led to an improved knowledge of the biology of the androgen receptor and a better understanding of how to assess for disease progression and the a...
|
Robert Dreicer,
Martin Gleave,
Adam S. Kibel,
J. Brantley Thrasher,
Judd W. Moul
et al.
|
S482-S484
|
|
|
|
Traditional Approaches to Androgen Deprivation Therapy
Abstract: For most of the past 25 years, 1 of the favored approaches to treating prostate cancer has been the suppression of circulating testosterone with luteinizing hormone-releasing hormone (LHRH) ...
|
Judd W. Moul,
Christopher P. Evans,
Leonard G. Gomella,
Mack Roach,
Robert Dreicer
et al.
|
S485-S493
|
|
|
|
New Data, New Paradigms for Treating Prostate Cancer Patients—VI: Novel Hormonal Therapy Approaches
Until the 1980s, testosterone suppression for men with advanced prostate cancer was managed surgically, with bilateral orchiectomy, or medically, with diethylstilbestrol, a drug that was associated wi...
|
Robert Dreicer,
Dean F. Bajorin,
David G. McLeod,
Daniel P. Petrylak,
Judd W. Moul
et al.
|
S494-S498
|
|
|
|
Conclusion
In 2010, >2 million men in the United States were living with prostate cancer, and almost 200 000 Americans were diagnosed with prostate cancer, meaning a new case was diagnosed almost every 3 minu...
|
Robert Dreicer,
Judd W. Moul
|
S499
|
|
| Frontmatter |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Title Page
|
|
A1
|
|
|
|
Aims and Scope
|
|
A2
|
|
|
|
Table of Contents
|
|
A3
|
|
